ADC Therapeutics SA
ADCT- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001771910
No open-market purchases or sales by ADC Therapeutics SA insiders were filed in the last 90 days; 113 institutions reported holding it in 13F filings for Q2 2026, worth $86.3M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding ADC Therapeutics SA changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 86 | 106 | +20 |
| Shares | 68.0M | 67.8M | −120.4K (−0.2%) |
| Value | $182.1M | $271.3M | +$89.2M (+49.0%) |
New holders (23)
Institutions that held ADC Therapeutics SA at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| TCG Crossover Management, LLC | 1,390,175 | $5.56M | 0.27% |
| Lynx1 Capital Management LP | 1,325,848 | $5.30M | 1.08% |
| Opaleye Management Inc. | 682,529 | $2.73M | 0.39% |
| Jane Street Group, LLC | 487,868 | $1.95M | 0.00% |
| Wellington Management Group LLP | 250,084 | $1.00M | 0.00% |
| Acadian Asset Management LLC | 227,500 | $906.0K | 0.00% |
| Walleye Capital LLC | 177,032 | $708.1K | 0.01% |
| Marshall Wace, LLP | 159,993 | $640.0K | 0.00% |
| XTX Topco Ltd | 91,579 | $366.3K | 0.02% |
| Voleon Capital Management LP | 70,311 | $281.2K | 0.01% |
| ExodusPoint Capital Management, LP | 45,941 | $183.8K | 0.00% |
| Two Sigma Investments, LP | 45,458 | $181.8K | 0.00% |
| R Squared Ltd | 14,714 | $58.9K | 0.03% |
| Atom Investors LP | 13,131 | $52.5K | 0.00% |
| Jump Financial, LLC | 11,591 | $46.4K | 0.00% |
| HSBC Holdings PLC | 10,521 | $41.6K | 0.00% |
| Optiver Holding B.V. | 1,306 | $5.22K | 0.00% |
| SRS Capital Advisors, Inc. | 672 | $2.69K | 0.00% |
| UMA Financial Services, Inc. | 228 | $912 | 0.00% |
| Quadrant Capital Group LLC | 173 | $692 | 0.00% |
| Rockefeller Capital Management L.P. | 165 | $660 | 0.00% |
| Allworth Financial LP | 5 | $20 | 0.00% |
| Clearstead Advisors, LLC | 1 | $4 | 0.00% |
Sold out (3)
Institutions that held ADC Therapeutics SA at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Woodline Partners LP | 842,900 | $2.26M |
| Susquehanna International Group, LLP | 115,232 | $308.8K |
| Virtu Financial LLC | 59,548 | $160.0K |